Skip to main content
Patient-Centered Outcomes Research Institute
  • Blog
  • Newsroom
  • Help Center
  • Subscribe
  • Careers
  • Contact

PCORI

Patient-Centered Outcomes Research Institute

Search form

  • Home
  • About Us
    • Our Programs
      • Clinical Effectiveness and Decision Science
      • Healthcare Delivery and Disparities Research
      • Evaluation and Analysis
      • Engagement
      • Research Infrastructure
    • Governance
      • Board of Governors
      • Methodology Committee
      • Committees
        • Engagement, Dissemination, and Implementation Committee
        • Research Transformation Committee
        • Science Oversight Committee
        • Finance and Administration Committee
        • Executive Committee
        • Governance Committee
          • Executive Evaluation and Compensation Subcommittee
        • Scientific Publications Committee
        • Selection Committee
    • Financials and Reports
      • Our Funding
    • Procurement Opportunities
      • Operations Support Funding
      • Research Support Funding
      • Contracted Projects
    • Our Staff
      • Staff Conflict of Interest Disclosures
      • Executive Team
      • Office of the Executive Director
        • Evaluation and Analysis
        • Research Infrastructure
      • Office of the General Counsel
      • Science
        • Office of the Chief Science Officer
        • Clinical Effectiveness and Decision Science
        • Healthcare Delivery and Disparities Research
        • Peer Review
        • Research Synthesis
      • Engagement
        • Communications
        • Dissemination and Implementation
        • Engagement Awards
        • Office of the Chief Engagement and Dissemination Officer
        • Public and Patient Engagement
        • Public Policy
        • Training
      • Operations
        • Office of the Chief Operations Officer
        • Administrative Services
        • Finance
        • Human Resources
        • Information Technology
        • Procurement
      • Program Support and Information Management
        • Contract Management
        • Data Management & Operations Support
        • Merit Review
        • Office of the Chief Program Support Officer
    • Contact Us
  • Research & Results
    • Explore Our Portfolio
      • Completed Projects With Results
      • Highlights of PCORI-funded Research Results
    • Putting Evidence to Work
      • Evidence for Decisions
      • CME/CE Activities
      • Funded Projects: Putting Research Results into Practice
      • Dissemination and Implementation Framework and Toolkit
    • Peer Review
      • Who Are Our Peer Reviewers?
      • Sign Up to Become a Peer Reviewer
      • Peer Review FAQ
      • Step-by-Step Instructions for Awardees: Peer Review of Draft Final Research Report
    • Research Topics
    • Evidence Synthesis
    • About Our Research
      • How We Select Research Topics
        • Generation and Prioritization of Topics for Funding Announcements
        • Topics in the Prioritization Pathway
      • Research We Support
        • National Priorities and Research Agenda
          • How We Developed our National Priorities and Research Agenda
            • Public Comments for PCORI’s National Priorities and Research Agenda
      • Collaborating with Other Research Funders
      • Research Methodology
        • PCORI Methodology Standards
          • Suggest a Topic Area for New Methodology Standards
        • The PCORI Methodology Report
        • PCORI Methodology Standards and Report FAQ
        • Methodology Standards Academic Curriculum
          • Category 1: Standards for Formulating Research Questions
          • Category 2: Standards Associated with Patient-Centeredness
          • Category 3: Standards for Data Integrity and Rigorous Analyses
          • Category 4: Standards for Preventing and Handling Missing Data
          • Category 5: Standards for Heterogeneity of Treatment Effects
          • Category 6: Standards for Data Registries
          • Category 7: Data Networks as Research-Facilitating Structures
          • Category 8: Standards for Causal Inference Methods
          • Category 9: Standards for Adaptive and Bayesian Trial Designs
          • Category 10: Standards for Studies of Diagnostic Tests
          • Category 11: Standards for Systematic Reviews
        • Methodology Committee - Workshops and Events
      • Evaluating Our Work
        • Planning Our Evaluation, Reporting the Results
          • PCORI's Goals
        • Evaluating Key Aspects of Our Work
  • Engagement
    • What We Mean by Engagement
      • PCORI’s Stakeholders
    • Engagement Awards
    • Engagement in Health Research Literature Explorer
    • Engage with Us
      • Voices of Engagement
        • David White
        • Elizabeth Cox
        • Regina Greer-Smith
        • Kimberly Jinnett
        • Toya Burton
        • David Hahn
        • Rebekah Angove
        • Neely Williams
        • Peter W. Thomas
        • Megan O'Boyle
        • Stephanie Buxhoeveden
        • Sergio Sanchez
      • Become a Merit Reviewer
        • PCORI Stakeholder Reviewer Communities
        • Reviewer Qualifications
        • Reviewer Responsibilities
      • Become a Peer Reviewer
      • PCORI's Advisory Panels
        • Advisory Panel on Clinical Effectiveness and Decision Science (CEDS)
          • Biographies - Advisory Panel on Clinical Effectiveness and Decision Science (CEDS)
        • Advisory Panel on Healthcare Delivery and Disparities Research (HDDR)
          • Biographies - Advisory Panel on Healthcare Delivery and Disparities Research (HDDR)
        • Advisory Panel on Clinical Trials
          • Biographies - Advisory Panel on Clinical Trials
          • Advisory Panel on Clinical Trials Subcommittee on Recruitment, Accrual, and Retention
          • Advisory Panel on Clinical Trials Subcommittee on the Standardization of Complex Concepts and their Terminology
        • Advisory Panel on Patient Engagement
          • Biographies - Advisory Panel on Patient Engagement
        • Advisory Panel on Rare Disease
          • Biographies - Advisory Panel on Rare Disease
        • Advisory Panel Openings
        • PCORI Advisory Panels FAQs
      • Become a PCORI Ambassador
        • History of the Ambassador Program
        • About Ambassadors
        • Who are PCORI's Ambassadors?
          • PCORI Individual Ambassadors
          • PCORI Organizational Ambassadors
          • PCORI Ambassadors: Northeast Region
          • PCORI Ambassadors: South Region
          • PCORI Ambassadors: Midwest Region
          • PCORI Ambassadors: Western Region
        • Ambassador Program Interest Form
      • Provide Input
      • Suggest a Patient-Centered Research Question
        • How to Write a Research Question
      • Participate in PCORI Events
        • PCORI in Practice
  • Funding Opportunities
    • What & Who We Fund
    • What You Need to Know to Apply
      • Glossary
    • Applicant Training
    • Merit Review Process
      • Merit Review Criteria
      • General Merit Reviewer Resources
        • Meet Our Reviewers
        • Reviewer FAQs
    • Research Support Funding Opportunities
      • Eugene Washington PCORI Engagement Awards
        • Eugene Washington PCORI Engagement Awards: Review Process
        • Eugene Washington PCORI Engagement Awards FAQs
        • Eugene Washington PCORI Engagement Awards: Recently Funded Projects
      • Pipeline to Proposal Awards
        • Pipeline to Proposal Awards: Program Offices
        • Pipeline to Proposal Awards: Three-Tiered Program
      • The PCORI Matchmaking App Challenge
        • 2014 PCORI Matchmaking App Challenge - Runners Up
          • Judges for PCORI 2014 Challenge
        • PCORI Challenge Initiative - 2013
          • Judges for PCORI 2013 Challenge
      • Research Support Funding
        • VOI Analysis
    • Awardee Resources
      • Closed PCORI Funding Announcements
    • Help Center
  • Meetings & Events
    • Upcoming
    • Past Events

You are here

  • Research & Results
  • Explore Our Portfolio
  • Determining the Effectiveness of Earl...
Sign Up for Updates to This Study 

Determining the Effectiveness of Early Intensive versus Escalation Approaches for the Treatment of Relapsing-Remitting Multiple Sclerosis (DELIVER-MS)

Project Summary  

Multiple sclerosis (MS) is a leading cause of disability among young adults in North America and Europe and affects over 2.5 million people worldwide. When deciding on a disease-modifying treatment (DMT), persons with relapsing-remitting multiple sclerosis (PwRRMS) and neurologists are currently faced with the dilemma of adopting one of two treatment approaches: an escalation approach, starting a drug that is considered safe but with a modest likelihood to control the MS activity (attacks and new lesions), and escalating to more potent therapies in the face of continued disease activity; or an early highly effective treatment (EHT) approach, which, in contrast, involves giving a high-efficacy drug, with the rare potential for significant adverse effects, as the first-line treatment. Despite significant interest from both patients and care providers on this topic, there is currently no evidence comparing these two approaches in a head-to-head trial.

This study is a multicenter randomized clinical trial. Subjects will be randomized in a 1:1 ratio to a specific approach for the first-line therapy, EHT, or escalation. The study population will be PwRRMS who have never been on a DMT recruited from MS treatment centers in the United States and the United Kingdom. Minimal entry criteria were selected to ensure the study will include patients who are representative of the general population of PwRRMS.

The aims for this study are to determine if either DMT approach (EHT or escalation) better slows brain volume loss, is safer, is more effective, or is better tolerated by PwRRMS. The study will measure how well the participants are functioning in several areas, including cognition, arm and leg function, and eyesight. We will ask participants’ perspective of their MS symptoms, quality of life measures for neurological disease, and satisfaction regarding their DMT. We will record the treatment-emergent adverse effects, as treatment choices in MS are influenced by not only the potential benefits of treatment, but also—importantly—the perceived risks.

The results of the study will provide a framework for overall treatment choices. In clinical encounters neurologists commonly discuss with patients the lack of comparative data between these two approaches. The data produced will directly help PwRRMS weigh the balance between the potential benefits and risks of DMT by providing the benefits and risks of these two approaches. The results will also help insurance payers and government agencies make more informed decisions on medication coverage, with the overall cost of long-term disability being a driving factor. The study results will help guide overall treatment philosophy and will be applicable to a wide range of both existing and new therapies, meeting a significant unmet need in patient decision making and aiding the decision for medication approval by third parties. Thus, this project has the potential to affect a large number of PwRRMS.

Project Details

Principal Investigator
Daniel Ontaneda, MD
Other Principal Investigator
Nikolaos Evangelou, MD, DPhil
Project Status
In progress; Not yet recruiting
Board Approval Date
September 2017
Project End Date
March 2024
Organization
Cleveland Clinic Foundation
Year Awarded
2017
State
Ohio
Funding Announcement
Treatment of Multiple Sclerosis
Conditions 
Mental/Behavioral Health
Functional Limitations and Disabilities
Neurological Disorders
Multiple Sclerosis
Project Budget
$10,626,363
Page Last Updated: 
March 30, 2018

Research & Results

  • Explore Our Portfolio
  • Putting Evidence to Work
  • Peer Review
  • Research Topics
  • Evidence Synthesis
  • About Our Research

About Us

  • Our Programs
  • Governance
  • Financials and Reports
  • Procurement Opportunities
  • Our Staff
  • Contact Us

Research & Results

  • Explore Our Portfolio
  • Putting Evidence to Work
  • Peer Review
  • Research Topics
  • Evidence Synthesis
  • About Our Research

Engagement

  • What We Mean by Engagement
  • Engagement Awards
  • Engagement in Health Research Literature Explorer
  • Engage with Us

Funding Opportunities

  • What & Who We Fund
  • What You Need to Know to Apply
  • Applicant Training
  • Merit Review Process
  • Research Support Funding Opportunities
  • Awardee Resources
  • Help Center

Meetings & Events

April 24
PCORI Online: Cycle 1 2018 Application Submission Webinar
April 30
Board of Governors Meeting: April 30, 2018
May 2
Advisory Panel on Clinical Effectiveness and Decision Science Spring 2018 Meeting

PCORI

Footer contact address

Patient-Centered Outcomes
Research Institute

1828 L Street, NW, Suite 900
Washington, DC 20036
Phone: (202) 827-7700 | Fax: (202) 355-9558
info@pcori.org

Subscribe to Newsletter

Twitter Facebook LinkedIn Vimeo

© 2011-2018 Patient-Centered Outcomes Research Institute. All Rights Reserved.

Privacy Policy | Terms of Use | Trademark Usage Guidelines | Credits | Help Center